The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Improvement of Cardiovascular Risk Markers by Pioglitazone Is Independent From Glycemic Control
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Atherosclerosis--an inflammatory disease
Ross, R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901143400207 · Cited by 21,725
Haffner, S. M., Lehto, S., Rönnemaa, T., Pyörälä, K., & Laakso, M. (1998) · New England Journal of Medicine · doi:10.1056/nejm199807233390404 · Cited by 7,000
Ridker, P. M., Hennekens, C. H., Buring, J. E., & Rifai, N. (2000) · New England Journal of Medicine · doi:10.1056/nejm200003233421202 · Cited by 5,850
PPAR-γ agonists inhibit production of monocyte inflammatory cytokines
Jiang, C., Ting, A. T., & Seed, B. (1998) · Nature · doi:10.1038/34184 · Cited by 2,899
Bots, M. L., Hoes, A. W., Koudstaal, P. J., Hofman, A., & Grobbee, D. E. (1997) · Circulation · doi:10.1161/01.cir.96.5.1432 · Cited by 2,345
Regulation of the Hedgehog and Wingless signalling pathways by the F-box/WD40-repeat protein Slimb
Jiang, J., & Struhl, G. (1998) · Nature · doi:10.1038/35154 · Cited by 1,735
Inflammation as a Cardiovascular Risk Factor
Willerson, J. T., & Ridker, P. M. (2004) · Circulation · doi:10.1161/01.cir.0000129535.04194.38 · Cited by 1,304
Haffner, S. M., Greenberg, A. S., Weston, W. M., Chen, H., Williams, K., & Freed, M. I. (2002) · Circulation · doi:10.1161/01.cir.0000025403.20953.23 · Cited by 884
Pasceri, V., Chang, J., Willerson, J. T., & Yeh, E. T. H. (2001) · Circulation · doi:10.1161/01.cir.103.21.2531 · Cited by 831
Blankenberg, S., Rupprecht, H. J., Poirier, O., Bickel, C., Smieja, M., Hafner, G., Meyer, J., Cambien, F., & Tiret, L. (2003) · Circulation · doi:10.1161/01.cir.0000058700.41738.12 · Cited by 755
Macrophages in Human Atheroma Contain PPARγ
Marx, N., Sukhova, G., Murphy, C., Libby, P., & Plutzky, J. (1998) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65540-x · Cited by 529
Self-citationAukrust, P., Müller, F., Ueland, T., Berget, T., Aaser, E., Brunsvig, A., Solum, N. O., Forfang, K., Frøland, S. S., & Gullestad, L. (1999) · Circulation · doi:10.1161/01.cir.100.6.614 · Cited by 506
Evidence for a Potent Antiinflammatory Effect of Rosiglitazone
Mohanty, P., Aljada, A., Ghanim, H., Hofmeyer, D., Tripathy, D., Syed, T., Al-Haddad, W., Dhindsa, S., & Dandona, P. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-032103 · Cited by 379
Bots, M. L., Evans, G. W., Riley, W. A., & Grobbee, D. E. (2003) · Stroke · doi:10.1161/01.str.0000102044.27905.b5 · Cited by 379
Evaluating Novel Cardiovascular Risk Factors: Can We Better Predict Heart Attacks?
Ridker, P. M. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-130-11-199906010-00018 · Cited by 323
Prevention Conference VI: Diabetes and Cardiovascular Disease: Writing Group I: Epidemiology
Howard, B. V., Rodriguez, B. L., Bennett, P. H., Harris, M. I., Hamman, R., Kuller, L. H., Pearson, T. A., & Wylie-Rosett, J. (2002) · Circulation · doi:10.1161/01.cir.0000013953.41667.09 · Cited by 308
Satoh, N., Ogawa, Y., Usui, T., Tagami, T., Kono, S., Uesugi, H., Sugiyama, H., Sugawara, A., Yamada, K., Shimatsu, A., et al. (2003) · Diabetes Care · doi:10.2337/diacare.26.9.2493 · Cited by 289
Touboul, P.-J., Elbaz, A., Koller, C., Lucas, C., Adraï, V., Chédru, F., Amarenco, P., & Investigators, F. T. G. (2000) · Circulation · doi:10.1161/01.cir.102.3.313 · Cited by 270
Death, A. K., Fisher, E. J., McGrath, K. C. Y., & Yue, D. K. (2003) · Atherosclerosis · doi:10.1016/s0021-9150(03)00140-0 · Cited by 262
Marx, N., Froehlich, J., Siam, L., Ittner, J., Wierse, G., Schmidt, A., Scharnagl, H., Hombach, V., & Koenig, W. (2003) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000054195.35121.5e · Cited by 257
Self-citationThe Prospective Pioglitazone Clinical Trial in Macrovascular Events (PROactive)
Charbonnel, B., Dormandy, J., Erdmann, E., Massi-Benedetti, M., Skene, A., & PROactive Study Group (2004) · Diabetes Care · doi:10.2337/diacare.27.7.1647 · Cited by 231
Cipollone, F., Mezzetti, A., Porreca, E., Di Febbo, C., Nutini, M., Fazia, M., Falco, A., Cuccurullo, F., & Davì, G. (2002) · Circulation · doi:10.1161/01.cir.0000025419.95769.f0 · Cited by 216
Marx, N., Imhof, A., Froehlich, J., Siam, L., Ittner, J., Wierse, G., Schmidt, A., Maerz, W., Hombach, V., & Koenig, W. (2003) · Circulation · doi:10.1161/01.cir.0000069272.06194.91 · Cited by 215
Self-citationVaro, N., Vicent, D., Libby, P., Nuzzo, R., Calle-Pascual, A. L., Bernal, M. R., Fernández-Cruz, A., Veves, A., Jarolim, P., Varo, J. J., et al. (2003) · Circulation · doi:10.1161/01.cir.0000074043.46437.44 · Cited by 202
Thiazolidinediones Block Fatty Acid Release by Inducing Glyceroneogenesis in Fat Cells
Tordjman, J., Chauvet, G., Quette, J., Beale, E. G., Forest, C., & Antoine, B. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m206999200 · Cited by 178
Kato, K., Satoh, H., Endo, Y., Yamada, D., Midorikawa, S., Sato, W., Mizuno, K., Fujita, T., Tsukamoto, K., & Watanabe, T. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.0648 · Cited by 160
Baseline reproducibility of B-mode ultrasonic measurement of carotid artery intima – media thickness
Tang, R., Hennig, M., Thomasson, B., Scherz, R., Ravinetto, R., Catalini, R., Rubba, P., Zanchetti, A., & Bond, M. G. (2000) · Journal of Hypertension · doi:10.1097/00004872-200018020-00010 · Cited by 149
Antiinflammatory and Antiarteriosclerotic Effects of Pioglitazone
Ishibashi, M., Egashira, K., Hiasa, K., Inoue, S., Ni, W., Zhao, Q. D., Usui, M., Kitamoto, S., Ichiki, T., & Takeshita, A. (2002) · Hypertension · doi:10.1161/01.hyp.0000036396.64769.c2 · Cited by 141
Derosa, G., Cicero, A. F. G., Gaddi, A. V., Ragonesi, P. D., Fogari, E., Bertone, G., Ciccarelli, L., & Piccinni, M. N. (2004) · Clinical Therapeutics · doi:10.1016/s0149-2918(04)90074-4 · Cited by 128
Ragaglitazar Improves Glycemic Control and Lipid Profile in Type 2 Diabetic Subjects
Saad, M. F., Greco, S. N., Osei, K., Lewin, A. J., Edwards, C., Nunez, M., Reinhardt, R. R., & for the Ragaglitazar Dose-Ranging Study Group (2004) · Diabetes Care · doi:10.2337/diacare.27.6.1324 · Cited by 106
Ferroni, P., Basili, S., Martini, F., Cardarello, C. M., Ceci, F., Franco, M. D., Bertazzoni, G., Gazzaniga, P. P., & Alessandri, C. (2003) · Journal of Investigative Medicine · doi:10.1136/jim-51-05-17 · Cited by 105
Ito, H., Nakano, A., Kinoshita, M., & Matsumori, A. (2003) · Laboratory Investigation · doi:10.1097/01.lab.0000106724.29121.da · Cited by 104
Tan, M. H., Johns, D., Strand, J., Halse, J., Madsbad, S., Eriksson, J. W., Clausen, J., Konkoy, C. S., Herz, M., & for the GLAC Study Group (2004) · Diabetic Medicine · doi:10.1111/j.1464-5491.2004.01258.x · Cited by 73
Effect of rosiglitazone on restenosis after coronary stenting in patients with type 2 diabetes
Osman, A., Otero, J., Brizolara, A. A., Waxman, S., Stouffer, G. A., Fitzgerald, P. J., & Uretsky, B. F. (2004) · American Heart Journal · doi:10.1016/j.ahj.2003.12.006 · Cited by 71
Tan, M. H., Johns, D., González-Gálvez, G., Antúnez, O., Fabián, G., Flores-Lozano, F., Zúñiga-Guajardo, S., de la Garza, E. R. Z., Morales, H., Konkoy, C. S., et al. (2004) · Clinical Therapeutics · doi:10.1016/s0149-2918(04)90068-9 · Cited by 66
Leugers, A., Lohrmann, J., Ernst, S., Sobel, B. E., Bode, C., Nordt, T. K., & Zirlik, A. (2004) · Thrombosis and Haemostasis · doi:10.1160/th03-06-0384 · Cited by 57
He, G., Pedersen, S. B., Bruun, J. M., Lihn, A. S., & Richelsen, B. (2003) · Hormone and Metabolic Research · doi:10.1055/s-2003-38386 · Cited by 43
Han, K. H., & Quehenberger, O. (2000) · Trends in Cardiovascular Medicine · doi:10.1016/s1050-1738(00)00076-1 · Cited by 24
Exploring options for improving healthcare
Wang, S. S., Mendelson, D. N., Schulman, K. A., et al. (2003) · American Heart Journal · doi:10.1016/j.ahj.2003.09.006 · Cited by 16
Cited by
Dormandy, J. A., Charbonnel, B., Eckland, D. J., Erdmann, E., Massi-Benedetti, M., Moules, I. K., Skene, A. M., Tan, M. H., Lefèbvre, P. J., Murray, G. D., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67528-9 · Cited by 4,129
Chronic Adipose Tissue Inflammation Linking Obesity to Insulin Resistance and Type 2 Diabetes
Zatterale, F., Longo, M., Naderi, J., Raciti, G. A., Desiderio, A., Miele, C., & Beguinot, F. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2019.01607 · Cited by 1,180
“Furthermore, the ability of TZDs to reduce circulating inflammatory mediators (such as CRP and MCP-1) seems to be independent of glycemic control (Pfützner et al., 2005).”
BackgroundObesity, inflammation, and atherosclerosis
Rocha, V. Z., & Libby, P. (2009) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2009.55 · Cited by 994
International Union of Pharmacology. LXI. Peroxisome Proliferator-Activated Receptors
Michalik, L., Auwerx, J., Berger, J. P., Chatterjee, V. K., Glass, C. K., Gonzalez, F. J., Grimaldi, P. A., Kadowaki, T., Lazar, M. A., O’Rahilly, S., et al. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.4.5 · Cited by 1,000
Goldberg, R. B. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-2534 · Cited by 644
Metadata
- Authors
- Pfützner, A., Marx, N., Lübben, G., Langenfeld, M., Walcher, D., Konrad, T., & Forst, T.
- Venue
- Journal of the American College of Cardiology
- Publisher
- Elsevier BV
- Published
- 2005-06
- Volume
- 45
- Issue
- 12
- Pages
- 1925-1931
- ISSN
- 0735-1097 (ISSN-L)
- OpenAlex
- W174705705
- Cited by
- 268
- References
- 39
- FWCI
- 22.07
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.